Patients with various malignancies were investigated for the presence of anti-gamma-globulin factors (AGGF). The cases with neoplasms of different tissues showed a significative incidence of positive tests for the AGGF as detected by the latex slide test (26.4%), human FII tanned sheep cell agglutination (34.5%) and sensitized sheep cell agglutination (8.4%). In the myeloid and lymphatic leukemias the incidence of AGGF was not higher than in patients with other diseases.
Get full access to this article
View all access options for this article.
References
1.
AndersonR. E., WalfordR. L., and DoyleP. C.: Leukocyte antibodies in acute leukemia of the monocytic and monocytoid forms.Am. J. Clin. Path., 36: 25–30, 1961.
2.
BonomoL., DammaccoF., PintoL., and BarbieriG.: Thyroglobulin antibodies in leprosy.Lancet, 2: 807–809, 1963.
3.
BonomoL., GillardiU., and TursiA.: Antigammaglobulin and antinuclear factors in chronic bronchitis.Am. J. Clin. Path., 45: 313–322, 1966.
4.
BonomoL., e TursiA.: I fattori antigammaglobuline: distribuzione nei tessuti e significato. Studio con l'immunofluorescenza in varie malattie.Rec. Progr. Med., 41: 604–614, 1966.
5.
BurtinP., von KleistS., RappW., LoisillierF., BonattiA., et GrabarP.: Auto-anticorps chez les cancéreux.Presse Med., 73: 2599–2603, 1965.
6.
DameshekW., and GunzF.: Leukemia.2nd ed., p. 344, Grune and Stratton, New York, 1964.
7.
FairleyG. H., and AkersR. J.: Antibodies to blood group A and B substances in reticuloses.Brit. J. Haemat, 8; 375–391, 1962.
8.
FairleyG. H., and MatthiasJ. Q.: Cortisone and skin sensitivity to tuberculin in reticuloses.Brit. Med. J.:2: 433–436, 1960.
9.
GreenwoodR., SmellieH., BarrM., and CunliffeA. C.: Circulating antibodies in sarcoidosis.Brit. Med. J., 1: 1388–1391, 1958.
10.
HudsonR. P., and WilsonS. J.: Hypogammaglobulinemia and chronic lymphatic leukaemia.Cancer, 13: 200–204, 1960.
IsraelL., MawasC., BouvrainA., MannoniP., et SorsC.: Etude de l'hypersensibilité retardée à la tuberculine chez 130 cancéreux adultes. Effets du B.C.G.Pathologie-Biologie, 15: 597–601, 1967.
13.
LevinA. G., CustodioD. B., MandelE. E., and SouthamC. M.: Rejection of cancer homotransplants by patients with debilitating non-neoplastic diseases.Ann. N. Y. Acad. Sci., 120: 410–423, 1964.
14.
Mc KelveyE. M., and FaheyJ. L.: Immunoglobulin changes in disease: quantitation on the basis of heavy polypeptide chains, IgG (γG), IgA (γA), and IgM (γM), and of light polypeptide chains, type K (I) and type L (II).J. Clin. Invest., 44: 1778–1787, 1965.
15.
MillerD. G.: Patterns of immunological deficiency in lymphomas and leukemia.Ann. Intern. Med., 57: 703–716, 1962.
16.
PodliachoukL., EyquemA., Lille-SzyszkowiczI., GabayP., et SaracinoR. T.: Les anti-γ-globulines dans le sérum des cancéreux non transfusés.Ann. Inst. Pasteur, 113: 625, 1967.
17.
TeeD. E. H., WangM., and WatkinsJ.: Antigenic properties of human tumours.Nature, 204: 897–898, 1964.
